According to Fortune Business Insights, the global artificial intelligence (AI) in drug discovery market was valued at USD 3.00 billion in 2022 and is projected to grow from USD 3.54 billion in 2023 to USD 7.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2% during the forecast period (2023–2030). In 2022, North America dominated the market with a 69.33% share.